The IMARC Group’s latest research report, titled “Oral Proteins and Peptides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” offers a comprehensive analysis of the oral proteins and peptides market forecast. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.
Oral Proteins and Peptides Market Trends:
The global market is majorly driven by the increasing prevalence of chronic diseases and nutritional deficiencies, which has heightened the need for protein and peptide supplements to support health and recovery. Another significant factor is the growing awareness of the benefits of protein and peptide supplementation among health-conscious consumers. As individuals become more aware of the importance of protein in muscle maintenance, weight management, and immune function, there is a rising demand for oral protein and peptide products. Furthermore, rapid technological advancements in protein and peptide formulations also contribute to market growth. Innovations in delivery systems, such as improved absorption and bioavailability, make oral protein and peptide products more effective and appealing. Advances in biotechnology and synthetic biology have enabled the development of more targeted and specialized peptides, expanding their therapeutic applications and enhancing their market potential.
Get Sample Copy of Report at – https://www.imarcgroup.com/oral-proteins-peptides-market/requestsample
Oral Proteins and Peptides Market Scope & Growth Analysis:
The global oral proteins and peptides market encompasses a wide range of products designed to support health, wellness, and medical conditions through dietary supplements and therapeutic applications. The market scope includes various types of oral proteins and peptides, such as whey protein, casein, soy protein, collagen peptides, and therapeutic peptides used in medical treatments. Market analysis indicates robust growth driven by increasing health awareness, technological advancements, and the rising prevalence of chronic diseases. The market is characterized by a diverse product range, catering to different consumer needs, including sports nutrition, weight management, and medical nutrition. The competitive landscape is marked by ongoing innovations in product formulations, delivery systems, and personalized nutrition solutions.
Competitive Landscape with Key Players:
- Amryt Pharma Plc
- AstraZeneca PLC
- Biocon Limited
- Novo Nordisk A/S
- Oramed Ltd
- Proxima Concepts Limited
Key Market Segmentation:
Drug Type Insights:
- Linaclotide
- Plecanatide
- Calcitonin
- Insulin
- Octreotide
Application Insights:
- Gastric and Digestive Disorders
- Bone Diseases
- Diabetes
- Hormonal Disorders
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Why Choose IMARC Research Report:
- Strong Market Research Expertise
- Targeted Marketing Strategies
- Innovative Solutions
- Comprehensive Analysis
- Accuracy and Reliability
- Provides Insightful Forecasts
- Available Customization Options
- Strong Customer Service
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
